Vicapsys Life Sciences, Inc.
VICP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $60,073 | $23,666 | $7,644 | $8,828 |
| - Cash | $12 | $9 | $14 | $217 |
| + Debt | $579 | $354 | $0 | $0 |
| Enterprise Value | $60,641 | $24,010 | $7,630 | $8,611 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$31 | -$31 |
| % Margin | – | – | – | – |
| EBITDA | -$900 | -$1,016 | -$613 | -$306 |
| % Margin | – | – | – | – |
| Net Income | -$990 | -$1,182 | -$985 | -$237 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.029 | -0.034 | -0.032 | -0.013 |
| % Growth | 15.8% | -5.9% | -141% | – |
| Operating Cash Flow | -$122 | -$418 | -$238 | -$444 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$122 | -$418 | -$238 | -$444 |